[Clinical trial in patients with infectious diseases of a new injectable cephalosporin derivative: lysine salt of cephalexin].
D000038:Abscess / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000188:drug therapy*; D002506:Cephalexin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002761:Cholangitis / Q000188:drug therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012141:Respiratory Tract Infections / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy
D002506:Cephalexin
Sperimentazione clinica su casistica infettivologica di un nuovo derivato cefalosporinico iniettabile: lisinato di cefalexina.